Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 4984

BillFederalSenateIntroduced
To amend the Controlled Substances Act to prohibit the deceptive sale of fentanyl, and for other purposes.
About This Bill
Introduced
Congress
117th (2021–2023)
Introduced
September 28, 2022
Cosponsors (2)
0D 2R
View PDF ↗

Summary

Highlight any text to annotate
Zero Tolerance for Deceptive Fentanyl Trafficking Act This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new criminal offense and penalties with respect to the deceptive sale of fentanyl, fentanyl analogues, or fentanyl-related substances.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.